Hemostatic/Fibrinolytic Predictors of Allograft Coronary Artery Disease after Cardiac Transplantation

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Vascular Medicine

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1358863X9700200406PMID 9575604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrinogen as a cardiovascular risk factor.

  1997cited by this paper
• Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.

  1995cited by this paper
• Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries.

  1995cited by this paper
• Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.

  1995cited by this paper
• Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.

  1995cited by this paper
• Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients.

  1994cited by this paper
• Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.

  1994cited by this paper
• Fibrinogen Plasma Levels as a Marker of Thrombin Activation: New Insights on the Role of Fibrinogen as a Cardiovascular Risk Factor

  1994cited by this paper
• The fibrin(ogen)olytic properties of cathepsin D.

  1994cited by this paper
• Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.

  1993cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• HEMOSTATIC CHANGES IN HEART TRANSPLANT RECIPIENTS AND THEIR RELATIONSHIP TO ACCELERATED CORONARY SCLEROSIS

  1993cited by this paper
• Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation.

  1993cited by this paper
• Intravascular Ultrasound Imaging of Coronary Arteries: Is Three Layers the Norm?

  1992cited by this paper
• Coronary venous intimal thickening in explanted cardiac allografts. Evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy.

  1992cited by this paper
• Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients.

  1992cited by this paper
• Long-term complications of cardiac transplantation.

  1991cited by this paper
• Lipoprotein (a) accumulates intracellularly in coronary atherectomy specimens obtained from primary and restenotic lesions after PTCA

  1991cited by this paper
• Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.

  1991cited by this paper
• Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.

  1991cited by this paper
• Intravascular ultrasound imaging of coronary arteries. Is three layers the norm

  1991cited by this paper
• Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening

  1991cited by this paper
• Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

  1991cited by this paper
• Increased platelet aggregation after heart transplantation: influence of aspirin.

  1991cited by this paper
• Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.

  1990cited by this paper
• Fate of fibrinogen in human arterial intima.

  1990cited by this paper
• Lipoprotein(a). A unique risk factor for atherothrombotic disease.

  1990cited by this paper
• Fibrinogen, factor VII clotting activity and coronary artery disease severity.

  1990cited by this paper
• Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.

  1989cited by this paper
• Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis.

  1989cited by this paper
• Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.

  1989cited by this paper
• Defibrinogenation by Arvin Reduces Air-Drying-lnduced Arteriosclerosis in Rat Carotid Artery

  1989cited by this paper
• Control of plasma fibrinogen levels.

  1989cited by this paper
• 8 Control of plasma fibrinogen levels

  1989cited by this paper
• Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation.

  1989cited by this paper
• Transient changes of serum lipoprotein(a) as an acute phase protein.

  1989cited by this paper
• Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987

  1988cited by this paper
• Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.

  1988cited by this paper
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Coagulation factors and the progress of coronary heart disease.

  1987cited by this paper
• Fibrinogen and risk of cardiovascular disease. The Framingham Study.

  1987cited by this paper
• Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient.

  1987cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Epidemiologic characteristics of platelet aggregability: Meade TW, Vickers MV, Thompson SG, et al. Br Med J 1985; 290:428–32

  1986cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Epidemiological characteristics of platelet aggregability.

  1985cited by this paper
• Fibrinogen degradation products influence PGI2 synthesis by cultured porcine aortic endothelial and smooth muscle cells.

  1984cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper
• Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.

  1982cited by this paper
• Relation between extent of coronary artery disease and blood viscosity.

  1980cited by this paper
• The effect of fibrin on cultured vascular endothelial cells.

  1979cited by this paper
• An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

  1975cited by this paper
• Isolation of elastase-like and chymotrypsin-like neutral proteases from human granulocytes.

  1974cited by this paper
• A modification of Movat's pentachrome stain.

  1972cited by this paper
• A modification of Movat's pentachrome stain.

  1972cited by this paper
• ATHEROGENESIS AND PLASMA CONSTITUENTS. I. DEMONSTRATION OF FIBRIN IN THE WHITE PLAQUE BY THE FLUORESCENT ANTIBODY TECHNIQUE.

  1964cited by this paper
• Studies on the character and staining of fibrin

  1962cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper
• The fibrin plate method for estimating fibrinolytic activity.

  1952cited by this paper

• Recurrent Disease after Heart Transplantation

  2014cites this paper
• The role of fibrinolytic genes and proteins in the development of allograft vascular disease.

  2011cites this paper
• Mikrovaskulopathie und Herztransplantation

  2008cites this paper
• The regulation and consequences of immune-mediated cell death in atheromatous diseases

  2007cites this paper
• Biomarkers after heart transplantation: nongenomic.

  2007cites this paper
• Endothelial Cell Biology: Inflammatory Biomarkers and Risk of Transplant Atherosclerosis

  2004cites this paper
• Thrombophiliediagnostik bei Empfängern von Organtransplantaten / Thrombophilia diagnostics in recipients of organ transplants

  2004cites this paper
• Circulating progenitor cells: search for an identity.

  2004cites this paper
• Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells

  2003cites this paper
• Usefulness of decreased levels of D-dimer in predicting progressive accelerated graft arteriosclerosis.

  2002cites this paper
• Microvascular prothrombogenicity and transplant coronary artery disease.

  2002cites this paper
• Prothrombogenic microvasculature and transplant outcome

  2002cites this paper
• Cardiomyopathy and heart transplantation in children.

  2002cites this paper
• The early detection of patients at risk of developing transplant-associated CAD is a major step toward inter- vention with adequate therapies for preventing or miti- gating

  2001cites this paper
• Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection

  2001cites this paper
• Management of Hyperlipidemia in the Stable Solid Organ Transplant Recipient

  2001cites this paper
• Immunohistochemical characterization of coronary thrombi in allograft vascular disease.

  2000cites this paper
• Anticoagulation factors as predictors of transplant-associated coronary artery disease.

  2000cites this paper
• Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation.

  1999cites this paper